(1)
Guertin, J.; LeLorier, J.; Durand, M.; Gow, R.; Holbrook, A.; Levine, M. IMPACT OF A RESTRICTIVE DRUG ACCESS PROGRAM ON THE RISK OF CARDIOVASCULAR ENCOUNTERS IN CHILDREN EXPOSED TO ADHD MEDICATIONS. J Popl Ther Clin Pharmacol 2018, 21 (3).